⌘K

Login Start Free

Home/Filings/4/0001062993-22-019753

4//SEC Filing

Hamilton Thomas Edward 4

Accession 0001062993-22-019753

CIK 0001374690other

View on SEC.gov Company Profile

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 6:54 AM ET

Size

5.4 KB

Accession

0001062993-22-019753

Insider Transaction Report

Form 4

Period: 2022-09-16

Larimar Therapeutics, Inc.LRMR

Hamilton Thomas Edward

Director

Transactions

Purchase
Common Stock
2022-09-16$3.15/sh+317,460$999,999→ 507,590 total

Holdings

Common Stock
(indirect: FA Life Sciences, Inc.)
159,433

Footnotes (1)

[F1]Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1

filerCIK 0001769848

Filing Metadata

Form type: 4
Filed: Sep 19, 8:00 PM ET
Accepted: Sep 20, 6:54 AM ET
Size: 5.4 KB

View on SEC.gov